INCY
$INCY
Incyte Corporation
Biopharmaceutical company focused on oncology and inflammation with Jakafi as lead drug.
Healthcare$92.95
+0.71 (+0.77%)
Day Range$91.72 - $93.57
Prev Close$92.24
Analyst Rating
Buy
17 Buy / 15 Hold / 1 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
INCY: Zynyz Approval, Mixed Fundamentals
Incyte's EU approval for Zynyz reshapes the growth narrative, but recent earnings volatility and mixed analyst actions leave the risk/reward balanced. This report breaks down valuation, catalysts, and key risks for $INCY.
Mar 16, 2026